Nature Search

Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction

A-M de Roda Husman
PJF Snijders
JMM Walboomers
Research01 Aug 1995
British Journal of Cancer

Volume: 72, P: 412-417
Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

M van Ballegooijen
ME van den Akker-van Marle
JDF Habbema
Research01 Sept 1997
British Journal of Cancer

Volume: 76, P: 651-657
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions

HJ Bontkes
TD de Gruijl
JA Kummer
Research01 Nov 1997
British Journal of Cancer

Volume: 76, P: 1353-1360
The role of Homeobox genes in normal hematopoiesis and hematological malignancies

JW van Oostveen
JJ Bijl
CJLM Meijer
Reviews03 Nov 1999
Leukemia

Volume: 13, P: 1675-1690
Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells

JJ Bijl
JW van Oostveen
CJLM Meijer
Research22 Oct 1998
Leukemia

Volume: 12, P: 1724-1732
Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma

M Frisch
B Glimelius
M Melbye
Research01 Dec 1998
British Journal of Cancer

Volume: 78, P: 1534-1538
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

FV Cromme
PFJ van Bommel
CJLM Meijer
Research01 Jun 1994
British Journal of Cancer

Volume: 69, P: 1176-1181
Cervical cancer prevention: who should receive vaccination?

Chris JLM Meijer
Johannes Berkhof
Peter JF Snijders
Comments & Opinion09 Oct 2007
Nature Clinical Practice Oncology

Volume: 5, P: 12-13
Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

FV Cromme
CJLM Meijer
JMM Walboomers
Research01 Jun 1993
British Journal of Cancer

Volume: 67, P: 1372-1380
Human papillomavirus and invasive cervical cancer in Brazil

J Eluf-Neto
M Booth
JMM Walboomers
Research01 Jan 1994
British Journal of Cancer

Volume: 69, P: 114-119
Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with ¹³¹I-labelled monoclonal antibody E48 IgG

M Gerretsen
AHGJ Schrijvers
GAMS van Dongen
Research01 Sept 1992
British Journal of Cancer

Volume: 66, P: 496-502
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency

S Bulk
J Berkhof
C J L M Meijer
ResearchOpen Access20 Mar 2007
British Journal of Cancer

Volume: 96, P: 1234-1236
Cervical cancer—should we abandon cytology for screening?

Convincing data have shown that human papillomavirus (HPV)-DNA testing predicts the development of high-grade cervical cancer better than cytology. However, for HPV-positive women, triage with cytology testing should be performed before colposcopy. The question on how to proceed if the cytology test in HPV-positive women is negative remains unclear.

Chris J. L. M. Meijer
Johannes Berkhof
News & Views11 Sept 2012
Nature Reviews Clinical Oncology

Volume: 9, P: 558-559
Screening comes of age and treatment progress continues

In 2013, studies confirmed that HPV infection of target cells predisposes to cervical (pre)cancer. In developed countries, HPV screening revealed superior protection than cytology screening. In India, visual inspection of the cervix after acetic acid application significantly reduced cervical cancer mortality after 12 years. Improved survival for women with advanced disease was observed after adjuvant bevacizumab.

Chris J. L. M. Meijer
Peter J. F. Snijders
News & Views21 Jan 2014
Nature Reviews Clinical Oncology

Volume: 11, P: 77-78
Novel molecular subtypes of cervical cancer — potential clinical consequences

The Cancer Genome Atlas Research Network recently published the most comprehensive, multi-omic molecular characterization of cervical cancers performed to date. The data reveal novel disease subtypes, and provide new insights into the aetiology and pathogenesis of cervical cancer. Importantly, the information obtained has potentially major clinical implications.

Chris J. L. M. Meijer
Renske D. M. Steenbergen
News & Views11 Apr 2017
Nature Reviews Clinical Oncology

Volume: 14, P: 397-398
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

S Bulk
J Berkhof
C J L M Meijer
ResearchOpen Access13 Dec 2005
British Journal of Cancer

Volume: 94, P: 171-175
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area

S Bulk
O Visser
C J L M Meijer
ResearchOpen Access26 Aug 2003
British Journal of Cancer

Volume: 89, P: 834-839
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker

RL ten Berge
JJ Oudejans
CJLM Meijer
Research01 Mar 2001
Leukemia

Volume: 15, P: 458-464
Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping

Stèfanie Dick
Frederique J. Vink
Johannes Berkhof
ResearchOpen Access06 Nov 2021
British Journal of Cancer

Volume: 126, P: 259-264
HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions

Marjolein van Zummeren
Wieke W. Kremer
Chris J. L. M. Meijer
Research22 Aug 2018
Modern Pathology

Volume: 31, P: 1842-1850
FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Roosmarijn Luttmer
Lise M A De Strooper
Chris J L M Meijer
ResearchOpen Access14 Jul 2016
British Journal of Cancer

Volume: 115, P: 579-587
Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

D C Rijkaart
V M H Coupe
C J L M Meijer
ResearchOpen Access31 Aug 2010
British Journal of Cancer

Volume: 103, P: 939-946
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

N W J Bulkmans
L Rozendaal
C J L M Meijer
ResearchOpen Access12 Apr 2005
British Journal of Cancer

Volume: 92, P: 1800-1802
Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women

M Molano
A J C van den Brule
N Munoz
ResearchOpen Access26 Nov 2002
British Journal of Cancer

Volume: 87, P: 1417-1421
High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum

M A E Nobbenhuis
T J M Helmerhorst
C J L M Meijer
ResearchOpen Access25 Jun 2002
British Journal of Cancer

Volume: 87, P: 75-80
High-risk HPV type-specific clearance rates in cervical screening

N W J Bulkmans
J Berkhof
C J L M Meijer
ResearchOpen Access06 Mar 2007
British Journal of Cancer

Volume: 96, P: 1419-1424
Characterization of cervical biopsies of women with HIV and HPV co-infection using p16^ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation

Wieke W. Kremer
Frederique J. Vink
Chris J. L. M. Meijer
Research06 Apr 2020
Modern Pathology

Volume: 33, P: 1968-1978
Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin's Disease

M. H Vermeer
D. F Dukers
R Willemze
Research01 Aug 2002
Modern Pathology

Volume: 15, P: 838-844
HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions

M C G Bleeker
J Berkhof
C J L M Meijer
ResearchOpen Access05 Apr 2005
British Journal of Cancer

Volume: 92, P: 1388-1392
p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population

Roosmarijn Luttmer
Maaike G Dijkstra
Chris J L M Meijer
Research06 May 2016
Modern Pathology

Volume: 29, P: 870-878
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

D C Rijkaart
J Berkhof
C J L M Meijer
ResearchOpen Access17 Jan 2012
British Journal of Cancer

Volume: 106, P: 975-981

Search

Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions

The role of Homeobox genes in normal hematopoiesis and hematological malignancies

Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells

Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

Cervical cancer prevention: who should receive vaccination?

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

Human papillomavirus and invasive cervical cancer in Brazil

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with ¹³¹I-labelled monoclonal antibody E48 IgG

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency

Cervical cancer—should we abandon cytology for screening?

Screening comes of age and treatment progress continues

Novel molecular subtypes of cervical cancer — potential clinical consequences

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area

Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women

High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum

High-risk HPV type-specific clearance rates in cervical screening

Characterization of cervical biopsies of women with HIV and HPV co-infection using p16^ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation

Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin's Disease

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

Search

Quick links

Search

Filter By:

Search

Quick links